ZURICH, Sept 3 (Reuters) - U.S. regulators approved Novartis AG's Omnitrope Pen 10 with liquid cartridge, a generic version of Pfizer Inc's human growth hormone Genotropin. The Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback